Skip to main content
. 2017 Sep 5;24(9):e00157-17. doi: 10.1128/CVI.00157-17

FIG 3.

FIG 3

Anti-F immunoglobulin G antibody level over time in subjects who received either the RSV vaccine (by dose) or the influenza vaccine. The geometric mean fold rise in the antibody level from that at the baseline is presented by day postdose. CI, confidence interval; F IgG, F-specific IgG; GLA, glucopyranosyl lipid A; RSV, respiratory syncytial virus; SE, stable emulsion; sF, soluble RSV fusion protein.